Knockdown of Bmi-1 impairs growth and invasiveness of human gastric carcinoma cells

Oncology Research

Volumn 17, Issue 11-12, 2009, Pages 613-620

  Xiao, Jun ^a   Deng, Changsheng ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

Apoptosis; Bmi 1; Gastric carcinoma; Proliferation; RNA interference (RNAi)

Indexed keywords

BMI1 PROTEIN; SHORT HAIRPIN RNA; BMI1 PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE INHIBITOR 2A; NUCLEAR PROTEIN; ONCOPROTEIN; REPRESSOR PROTEIN; SMALL INTERFERING RNA;

APOPTOSIS; ARTICLE; CELL INVASION; CELL PROLIFERATION; CONTROLLED STUDY; GROWTH INHIBITION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; STOMACH CARCINOMA; WESTERN BLOTTING; CANCER INVASION; DRUG ANTAGONISM; GENETICS; PATHOLOGY; PHYSIOLOGY; STOMACH TUMOR; TUMOR CELL LINE;

CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE INHIBITOR P16; HUMANS; NEOPLASM INVASIVENESS; NUCLEAR PROTEINS; PROTO-ONCOGENE PROTEINS; REPRESSOR PROTEINS; RNA INTERFERENCE; RNA, SMALL INTERFERING; STOMACH NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P14ARF;

EID: 70350498679     PISSN: 09650407     EISSN: None     Source Type: Journal    
DOI: 10.3727/096504009789745502     Document Type: Article

References (34)

1. Cervantes, A.; Rodriguez Braun, E.; Perez Fidalgo, A. Molecular biology of gastric cancer. Clin. Transl. Oncol. 9:208-215; 2007.
2. Haupt, Y.; Alexander, W. S.; Barn, G.; Klinken, S. P.; Adams, J. M. Novel zinc finger gene implicated as myc collaborator by retrovirally accelerated lymphomagenesis in E mu-myc transgenic mice. Cell 65:753-763; 1991.
3. van Lohuizen, M.; Verbeek, S.; Scheijen, B.; Wientjens, E.; Van der Guidon, H.; Berns, A. Identification of cooperating oncogenes in E mu-myc transgenic mice by provirus tagging. Cell 65:737-752; 1991.
4. van der Lugt, N. M.; Domen, J.; Linders, K.; Van Roon, M.; Robanu-Maardag, E.; te Riele, H.; van der Valk, M.; Deschamps, J.; Sofroniew, M.; van Lohuizen, M. Posterior transformation, neurological abnormalities, and severe hematopoietic defects in mice with a targeted deletion of the bmi-1 proto-oncogene. Genes Dev. 8:757-769; 1994.
5. Jacobs, J. J.; Kieboom, K.; Marino, S.; Depinho, R. A.; van Lohuizen, M. The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus. Nature 397:164-168; 1999.
6. Alkema, M. J.; Wiegant, J.; Raap, A. K.; Berns, A.; van Lohuizen, M. Characterization and chromosomal localization of the human protooncogene BMI-1. Hum. Mol. Genet. 2:1597-1603; 1993.
7. Pui, C. H.; Raimondi, S. C.; Murphy, S. B.; Ribeiro, R. C.; Kalwinsky, D. K.; Dahl, G. V.; Crist, W. M.; Williams, D. L. An analysis of leukemic cell chromosomal features in infants. Blood 69:1289-1293; 1987.
8. Berger, R.; Baranger, L.; Bernheim, A.; Valensi, F.; Flandrin, G. Cytogenetics of T-cell malignant lymphoma. Report of 17 cases and review of the chromosomal breakpoints. Cancer Genet Cytogenet. 36:123-130; 1988.
9. Vonlanthen, S.; Heighway, J.; Altermatt, H. J.; Gugger, M.; Kappeler, A.; Borner, M. M.; van Lohuizen, M.; Betticher, D. C. The bmi-1 oncoprotein is differentially expressed in non-small cell lung cancer and correlates with INK4A-ARF locus expression. Br. J. Cancer 84: 1372-1376; 2001.
10. Kim, J. H.; Yoon, S. Y.; Jeong, S. H.; Kim, S. Y.; Moon, S. K.; Joo, J. H.; Lee, Y.; Choe, I. S.; Kim, J. W. Overexpression of Bmi-1 oncoprotein correlates with axillary lymph node metastases in invasive ductal breast cancer. Breast 13:383-388; 2004.
11. Kim, J. H.; Yoon, S. Y.; Kim, C. N.; Joo, J. H.; Moon, S. K.; Choe, I. S.; Choe, Y. K.; Kim, J. W. The Bmi-1 oncoprotein is over expressed in human colorectal cancer and correlates with the reduced p16INK4a/p14ARF proteins. Cancer Lett. 203:217-214; 2004.
12. Sawa, M.; Yamamoto, K.; Yokozawa, T.; Kiyoi, H.; Hishida, A.; Kajiguchi, T.; Seto, M.; Kohno, A.; Kitamura, K.; Itoh, Y.; Asou, N.; Hamajima, N.; Emi, N.; Naoe, T. BMI-1 is highly expressed in M0-subtype acute myeloid leukemia. Int. J. Hematol. 82:42-47; 2005.
13. Cui, H.; Hu, B.; Li, T.; Ma, J.; Alam, G.; Gunning, W. T.; Ding, H. F. Bmi-1 is essential for the tumorigenicity of neuroblastoma cells. Am. J. Pathol. 170:1370-1378; 2007.
14. Merkerova, M.; Bruchova, H.; Kracmarova, A.; Klamova, H.; Brdicka, R. Bmi-1 over-expression plays a secondary role in chronic myeloid leukemia transformation. Leukemia Lymphoma 48:793-801; 2007.
15. Lee, K.; Adhikary, G.; Balasubramanian, S.; Gopalakrishnan, R.; McCormick, T.; Dimri, G. P.; Eckert, R. L.; Rorke, E. A. Expression of Bmi-1 in epidermis enhances cell survival by altering cell cycle regulatory protein expression and inhibiting apoptosis. J. Investig. Dermatol. 128:9-17; 2008.
16. Reinisch, C.; Kandutsch, S.; Uthman, A.; Pammer, J. BMI-1: A protein expressed in stem cells, specialized cells and tumors of the gastrointestinal tract. Histol. Histopathol. 21:1143-1149; 2006.
17. Huang, K. H.; Liu, J. H.; Li, X. X.; Song, L. B.; Zeng, M. S.; Guo, B. H. Association of Bmi-1 mRNA expression with differentiation, metastasis and prognosis of gastric carcinoma. J. South Med. Univ. 27:973-975; 2007.
18. Huang, K. H.; Liu, J. H.; Li, X. X.; Song, L. B.; Zeng, M. S.; Guo, B. H. Expression and clinical significance of Bmi-1 oncogene in gastric carcinoma. Chin. J. Clin. Oncol. 34:961-965; 2007.
19. Jemal, A.; Siegel, R.; Ward, E. Cancer statistics, 2008. CA Cancer J. Clin. 58:71-96; 2008.
20. Zhang, M.; Deng, C. S.; Zheng, J. J.; Xia, J. Curcumin regulated shift from Th1 to Th2 in trinitrobenzene sulphonic acid-induced chronic colitis. Acta Pharmacol. Sin. 27:1071-1077; 2006.
21. Riccardi, C.; Nicoletti, I. Analysis of apoptosis by propidium iodide staining and flow cytometry. Nat. Nat. Protoc. 1:1458-1461; 2006.
22. Lu, J.; Lin, W. H.; Chen, S. Y.; Longnecker, R.; Tsai, S. C.; Chen, C. L.; Tsai, C. H. Syk tyrosine kinase mediates Epstein-Barr virust latent membrane protein 2A-induced cell migration in epithelial cells. J. Biol. Chem. 281:8806-8814; 2006.
23. Yu, Q.; Su, B.; Liu, D.; Liu, B.; Fan, Y.; Wang, Y.; Meng, X. Antisense RNA-mediated suppression of Bmi-1 gene expression inhibits the proliferation of lung cancer cell line A549. Oligonucleotides 17:327-335; 2007.
24. Glinsky, G. V.; Berezovska, O.; Glinskii, A. B. Micro-array analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer. J. Clin. Invest. 115:1503-1521; 2005.
25. van Kemenade, F. J.; Raaphorst, F. M.; Lokzijl, T. B.; Fieret, E.; Hamer, K. M.; Satijn, D. P.; Otte, A. P.; Meijer, C. J. Coexpression of BMI-1 and EZH2 polycomb-group proteins is associated with cycling cells and degree of malignancy in B-cell non-Hodgkin lymphoma. Blood 97: 3896-3901; 2001.
26. Jacobs, J. J.; Jacqueline, J. L.; Kieboom, C.; Marino, S.; DePinho, R. A.; van Lohuizen, M. The oncogene and Polycomb group gene Bmi-1 regulates cell proliferation and senescence through the ink4a locus. Nature 397:164-165; 1999.
27. Sharpless, N. E.; DePinho, R. A. The INK4A/ARF locus and its two gene products. Curr. Opin. Genet Dev. 9:22-30; 1999.
28. Serrano, M. The INK4a/ARF locus in murine tumor genesis. Carcinogenesis 21:865-869; 2000.
29. Sherr, C. J. Tumor surveillance via the ARF-p53 pathway. Genes Dev. 12:2984-2991; 1998.
30. Sherr, C. J.; Roberts, J. M. CDK inhibitors: Positive and negative regulators of G1-phase progression. Genes Dev. 13:1501-1512; 1999.
31. Domri, G. P.; Martinez, J. L.; Jacobs, J. J.; Keblusek, P.; Itahanak, K.; van Lohuizen, M.; Campisi, J.; Wazer, D. E.; Band, V. The Bmi-1 oncogene induces telomerase activity and immortalizes human mammary epithelial cells. Cancer Res. 62:4736-4745; 2002.
32. Song, L. B.; Zeng, M. S.; Liao, W. T.; Zhang, L.; Mo, H. Y.; Liu, W. L.; Shao, J. Y.; Wu, Q. L.; Li, M. Z.; Xia, Y. F.; Fu, L. W.; Huang, W. L.; Dimri, G. P.; Band, V.; Zeng, Y. X. Bmi-1 is a novel molecular marker of nasopharyngeal carcinoma progression and immortalizes primary human nasopharyngeal epithelial cells. Cancer Res. 66:6225-6232; 2006.
33. Guo, W. J.; Zeng, M. S.; Yadav, A.; Song, L. B.; Guo, B. H.; Band, V.; Dimri, G. P. Mel-18 acts as a tumor suppressor by repressing Bmi-1 expression and down-regulating Akt activity in breast cancer cells. Cancer Res. 67:5083-5089; 2007.
34. Leung, R. K.; Whittaker, P. A. RNA interference: From gene silencing to gene-specific therapeutics. Pharmacol. Ther. 107:222-239; 2005.